New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 30, 2013
15:02 EDTENDP, WCRX, VRXSources: Endo Health talks with potential buyers, Reuters says
Endo Health Solutions Inc (ENDP) has held exploratory talks with potential buyers in recent weeks, says Reuters, adding that the talks included interested parties like Warner Chilcott(WCRX) and Valeant Pharmaceuticals (VRX), according to the sources. Reference Link
News For ENDP;WCRX;VRX From The Last 14 Days
Check below for free stories on ENDP;WCRX;VRX the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | all recent news | >>
May 24, 2013
16:21 EDTVRXOn The Fly: Closing Wrap
Subscribe for More Information
13:18 EDTVRXOn The Fly: Midday Wrap
Subscribe for More Information
12:33 EDTVRXValeant calls active, near deal to buy Bausch & Lomb
Subscribe for More Information
12:30 EDTVRXValeant near deal to acquire Bausch & Lomb for $9B, WSJ reports
Bausch & Lomb is close to a deal to sell itself to Valeant for $9B in a deal that could be done as early as next week, reports The Wall Street Journal, citing people familiar with the matter. Shares of Valeant are trading sharply higher following the report, up $8.43, or 11.29%, to $83.10.Reference Link
12:08 EDTVRXValeant up 11% after Dow says near deal to buy Bausch & Lomb
Subscribe for More Information
12:07 EDTVRXBausch & Lomb near deal to sell itself to Valeant for around $9B, Dow says
11:28 EDTWCRXOptions with decreasing implied volatility: WCRX P CBST NTI BBY PXP
May 23, 2013
11:37 EDTWCRXOptions with decreasing implied volatility: WCRX CBST NTI BBY TSLA
May 22, 2013
11:56 EDTWCRXOptions with decreasing implied volatility: WCRX NTI PXP AMRN BBY
10:00 EDTWCRXOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
06:24 EDTWCRXWarner Chilcott downgraded to Market Perform from Outperform at Leerink
Leerink downgraded Warner Chilcott as it does not expect a competitive bid for the company to emerge.
May 21, 2013
11:41 EDTWCRXOptions with decreasing implied volatility: SGMO WCRX NTI TSLA AMRN
10:00 EDTWCRXOn The Fly: Analyst Downgrade Summary
Today's noteworthy downgrades include: Acquity Group (AQ) downgraded to Neutral from Buy at Roth Capital... Beazer Homes (BZH) downgraded to Neutral from Buy at Sterne Agee... CME Group (CME) downgraded to Neutral from Outperform at Macquarie... Carnival (CCL) downgraded to Neutral from Buy at UBS... Coach (COH) downgraded to Equal Weight from Overweight at Morgan Stanley... Deutsche Bank (DB) downgraded to Neutral from Overweight at JPMorgan... First Republic Bank (FRC) downgraded to Hold from Buy at Jefferies... Franklin Resources (BEN) downgraded to Neutral from Outperform at Macquarie... Life Technologies (LIFE) downgraded to Underperform from Outperform at CLSA... Oil States (OIS) downgraded to Neutral from Buy at Sterne Agee... Raymond James (RJF) downgraded to Market Perform from Outperform at Wells Fargo... VF Corp. (VFC) downgraded to Market Perform from Outperform at Wells Fargo... WellCare (WCG) downgraded to Neutral from Buy at Goldman... Huaneng Power (HNP) downgraded to Neutral from Buy at Citigroup... Comerica (CMA) downgraded to Neutral from Buy at DA Davidson... Beazer Homes (BZH) downgraded at Sterne Agee... Oil States (OIS) downgraded at Sterne Agee... eHealth (EHTH) downgraded to Neutral from Buy at Lazard Capital... Carnival (CCL) downgraded to Market Perform from Outperform at Wells Fargo... Warner Chilcott (WCRX) downgraded to Neutral from Positive at Susquehanna.
07:18 EDTWCRXWarner Chilcott downgraded to Neutral from Positive at Susquehanna
Subscribe for More Information
May 20, 2013
16:51 EDTWCRXActavis, Warner Chilcott deal includes $160M termination fee
Subscribe for More Information
16:22 EDTWCRXOn The Fly: Closing Wrap
Subscribe for More Information
14:27 EDTWCRXActavis price target raised to $140 from $101 at Morgan Stanley
Morgan Stanley raised Actavis's price target to $140 due to Warner Chilcott (WCRX) deal accretion. Shares are Overweight rated.
14:05 EDTWCRXWarner Chilcott downgraded to Hold from Buy at Needham
Subscribe for More Information
13:06 EDTWCRXOn The Fly: Midday Wrap
Stocks on Wall Street were modestly higher at midday as the Dow and S&P seek to continue their march higher after closing last week at record levels. ECONOMIC EVENTS: In the U.S., the light domestic economic calendar included the Chicago Fed National Activity index, which slipped to -0.53 for April from its prior reading of -0.23. In Asia, the Hang Seng and Shanghai Composite both climbed after Chinese home prices were reported to have risen in April. COMPANY NEWS: Yahoo (YHOO) confirmed it is buying social media platform Tumblr for $1.1B, as widely reported over the weekend, and promised "not to screw it up" in its press release to announce the deal... Actavis (ACT) agreed to acquire Warner Chilcott (WCRX) in a stock-for-stock transaction valued at approximately $8.5B. The deal, which was approved by the boards of both companies, equates to a value of $20.08 per Warner Chilcott share based on Actavis' closing share price on Friday, the companies said. MAJOR MOVERS: Among the notable gainers were some other companies with M&A news: Acquity Group (AQ) shares more than doubled after Accenture (ACN) agreed to buy the company for $13.00 per American Depositary Share, and Pactera Technology (PACT) gained 31% after receiving a non-binding proposal from a Blackstone (BX) affiliate to be taken private for $7.50 per ADS. Among the noteworthy losers was XenoPort (XNPT), which fell 11% after one of its drugs failed in a Phase III trial for multiple sclerosis spasticity. Also lower were shares of Red Hat (RHT), which slid 4% following a downgrade to Market Perform at BMO Capital. INDICES: Near 1 pm ET, the Dow was up 13.67, or 0.09%, to 15,368.07; the Nasdaq was up 1.13, or 0.03%, to 3,500.10; and the S&P 500 was up 2.18, or 0.13%, to 1,669.65.
11:56 EDTWCRXOptions with decreasing implied volatility: SGMO WCRX TSLA CSC SUPN
1 | 2 | 3 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.